Skip to main content
Clinical Trials/CTRI/2022/04/042342
CTRI/2022/04/042342
Recruiting
Phase 3

A Randomized clinical trial to evaluate the efficacy of Ayurveda Interventions as an add on therapy on functional, cardiac autonomic and cortical excitability measures in ambulant patients with Duchenne Muscular Dystrophy (Mamsa medagata vata) ?

Dr Rashmi R0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Rashmi R
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Rashmi R

Eligibility Criteria

Inclusion Criteria

  • Genetically confirmed ambulant patients of Duchenne Muscular Dystrophy (DMD) with elevated serum creatinine kinase
  • Clinical signs consistent with DMD like progressive loss of function
  • delayed walking
  • frequent falls
  • di?culty with running and climbing stairs
  • positive Gower sign and calf pseudohypertrophy

Exclusion Criteria

  • Non\-ambulant patients with advanced symptoms of cardiomyopathy and respiratory complications
  • Other muscular dystrophies and myopathies like becker muscular dystrophy, congenital muscular dystrophies \- myelopathies, congenital myopathies and metabolic muscle diseases
  • Evidence of any malignancy
  • With contraindications for TMS like major head injury, epilepsy, metallic implants in head and neck areas
  • Patients under steroid medication for a duration of more than six months

Outcomes

Primary Outcomes

Not specified

Similar Trials